Lite Strategy, Inc. Comprehensive Income
Lite Strategy, Inc. (LITS) reported Comprehensive Income of -$11.19 million for the 12-month period ending 2013-06-30, per its 10-K filed 2013-09-18.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2013-09-18
- Lite Strategy, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2013 was -$11.19M.
- Lite Strategy, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2012 was -$7.52M.
- Lite Strategy, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2011 was -$6.78M.
- Lite Strategy, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2010 was -$7.90M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|
| 2013-06-30 | -$11.19M 10-K · filed 2013-09-18 |
| 2012-06-30 | -$7.52M 10-K · filed 2013-09-18 |
| 2011-06-30 | -$6.78M 10-K · filed 2013-09-18 |
| 2010-06-30 | -$7.90M 10-K · filed 2013-09-18 |
| 2009-06-30 | -$11.18M 10-K · filed 2013-09-18 |
| 2008-06-30 | -$12.41M 10-K · filed 2013-09-18 |
| 2007-06-30 | -$13.82M 10-K · filed 2013-09-18 |
| 2006-06-30 | -$7.39M 10-K · filed 2013-09-18 |
| 2005-06-30 | -$6.42M 10-K · filed 2013-09-18 |
| 2004-06-30 | -$8.57M 10-K · filed 2013-09-18 |
| 2003-06-30 | -$3.00M 10-K · filed 2013-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |